# persona_off · bixbench · bix-29-q3

[All trial-1 traces](../../README.md)

- Trial: **1**; endpoint: **original**; attempt: **1**.
- Native status: **scored**; normalized native score: **0/100**.
- Recorded protocol: `researcher-review-v2`.
- Actor, simulator, and judge: **GPT-6 Astra, low reasoning**.
- Scope: chronological shared messages and handoff fields. Private tool logs, system prompts, evaluator references, and raw API requests are not included.
- A repaired endpoint belongs to the same trial; it is not an independent repeat. Zero scores and missing scientific submissions are retained.

## Shared conversation

### Event 1 — Simulator

**Message**

````text
Inspect the supplied files and any repository documentation only; do not fit the final model yet. Report dimensions, subject identifiers and join cardinalities, relevant variable values and missingness, and whether the MH workbook duplicates the CSV. Identify evidence for coding BCG status, prior medical history, COVID-specific events and ordered severity, and patient interaction frequency (including patients_seen versus expect_interact). Propose an ordinal logistic regression including BCG, medical history, their interaction, and the required frequency adjustment. Explain the proposed analysis unit, handling of multiple AE/MH records, eligibility and missing-data rules, reference categories, and direction of the interaction odds ratio. Flag consequential ambiguities, especially treatment-group meaning, COVID event identification, history definition, and whether severity is defined only for COVID cases. Return an inspection summary and proposed approach for review before executing the analysis.
````

**Interaction**

````text
initial_request
````

**Phase**

````text
initial_inspection
````

**Action**

````text
continue
````

**Approve Approach**

````text
false
````

**Evidence**

````text
The supplied schemas identify DM, AE and MH inputs with shared USUBJID and TRTGRP fields; AESEV, medical-history fields, patients_seen and expect_interact are available, but their observed coding and intended definitions have not been inspected.
````

**Objectives Open**

````text
[
  "Inspect input coding, linkage and relevant missingness.",
  "Agree on outcome, exposure, history and frequency definitions and analysis unit.",
  "Execute the agreed ordinal interaction model and report its interaction odds ratio with retained analysis-script evidence."
]
````

### Event 14 — Actor

**Answer**

````text
Inspection only is complete; no model has been fitted. Approval is requested for the proposed definitions below.

INPUTS AND JOINS
• No README, codebook, protocol, or analysis repository was supplied; only task.json and the four data files are present.
• DM: 1,000 × 11; AE: 2,694 × 51; MH: 37,767 × 13. All contain the same 1,000 nonmissing USUBJIDs (lexical range BCG0001–BCG5500). DM has one row per person; AE has 1–16 (median 2), MH 34–42 (median 39). No exact duplicate rows. STUDYID is constant.
• DM→AE and DM→MH are one-to-many; AE→MH is many-to-many. An unaggregated three-way subject join produces 102,672 rows and is inappropriate for independent-person regression. There are 105 repeated subject/AESPID keys among nonmissing event IDs, so AESPID alone is not a unique event key.
• TRTGRP agrees across files: 500 BCG and 500 Placebo subjects. The MH workbook contains one sheet and is exactly equal to the CSV in shape, column order, values, missingness, and imported dtypes; use the CSV once.

CODING EVIDENCE
• BCG: propose B=1 for TRTGRP='BCG', B=0 for Placebo. This is study treatment-group status, not documented lifetime BCG vaccination or confirmed administration. No historical vaccination variable was found.
• Frequency: DM patients_seen is an ordered volume category: 1–50 (835), 51–100 (129), >100 (36). expect_interact is Yes (628)/No (372), a distinct expectation indicator, not frequency. Neither has missing values; no DM column has missing values. Propose categorical patients_seen adjustment, reference 1–50, without assuming equal spacing or assigning an invented midpoint to >100. expect_interact would be an optional sensitivity adjustment, not a substitute.
• MH comprises baseline HEALTH QUESTIONNAIRE (6,000 rows), acute respiratory symptoms (10,000), female reproductive history (3,520), and MEDICAL HISTORY (18,247). All visits are Screening-Day -3 to 1. Merely having an MH row cannot define history: everyone has many rows.
• Within MHSCAT='MEDICAL HISTORY', MHORRES is 1 for 17,055 records, 2 for 1,031, missing for 161. Strong internal evidence indicates 2=yes, 1=no: every response 2 has MHONGO recorded (910 Yes, 121 No), whereas no response 1 does; named Other diagnoses all have response 2. Thus ongoing status must not be used as the history-positive flag, since resolved histories also qualify. Numeric coding is inferred, not documented.
• Eighteen standard condition questions occur once per person, plus 247 Other diagnosis rows. Conditions include hypertension, diabetes, asthma, TB, cardiovascular disease, allergy, hay fever, chronic sinusitis, and Current respiratory tract infection. Missing history responses occur only for hay fever (81) and current respiratory infection (80). Any positive condition gives 567 history-positive people; 433 have no observed positive, but 31 of those have an unanswered condition. Overall MHORRES has 1,654 missing values, mostly in other questionnaire sections; MHTEST/MHTERM missingness largely reflects alternate record structures. MHDECOD is present for only 439 rows, so requiring it would miss histories.
• COVID identification: AEPT has COVID-19 (207), COVID-19 pneumonia (9), Asymptomatic COVID-19 (5), and SARS-CoV-2 test positive (3): 224 records, 197 people. AELLT corroborates these terms. AECAT='RTI' alone is nonspecific (1,020 rows); 223 of the COVID-specific records are RTI and one is Other. Do not classify generic RTI, cough, or all adverse events as COVID.
• AESEV takes 1,2,3,4 (all-AE counts 1,238/741/64/20), with 631 missing. Of 2,694 AE rows, 143 have all event data missing and appear to be subject placeholders. COVID-specific records have 48 missing AESEV values; patient maximum observed severity is 1:56, 2:79, 3:11, 4:7, entirely missing:44. Four people have both scored and unscored COVID records. AEHS is a separate 0–7 health-status field, not interchangeable with AESEV. The numeric severity order is plausible, but category labels are not supplied; I would not invent mild/moderate/severe/death labels.
• Seven COVID records have negative AESTDTC (-61 to -1), all with missing severity. Excluding those leaves 217 records in 190 people, including 37 without any severity and the same 153 with observed severity. Date origin is not documented.

PROPOSED PRIMARY ANALYSIS
1. Unit: one person, joined to DM after separate AE and MH aggregation. For qualifying COVID events, take the maximum AESEV (worst recorded severity), ordered 1<2<3<4. This prevents patients with more events/history rows from receiving greater weight. Do not deduplicate distinct rows solely on AESPID.
2. COVID eligibility: use the four explicit COVID/SARS-positive preferred terms above. Assuming AESTDTC is relative to baseline, restrict to AESTDTC>=0. Include only people with COVID-specific severity; do not assign noncases or missing severity to severity zero. This estimates severity conditional on documented COVID, not population-wide infection/severity burden.
3. History: use any MHORRES=2 in baseline MHSCAT='MEDICAL HISTORY', including Other diagnoses; reference is all standard questions explicitly negative. If a person has no positive but an unanswered condition, mark history unknown and exclude from the primary complete-case analysis. Any positive establishes history even with other unanswered questions. This broad, reproducible baseline-history definition includes allergies and acute baseline conditions; a chronic-comorbidity definition would be a different estimand and requires a specified condition list.
4. Missing severity: exclude people with no observed qualifying severity. Primary outcome is explicitly worst recorded severity, allowing the four people with a scored and unscored record; sensitivity analysis would exclude them because true worst severity may be underestimated. Exclude missing/invalid BCG, frequency, or history; do not impute absent history as no. Before history exclusions, there are 153 severity-observed candidates (149 with all qualifying COVID records scored).
5. Fit a proportional-odds ordinal logistic regression: logit[P(Y>k)/P(Y<=k)] = alpha_k + beta_B B + beta_H H + beta_BH(B×H) + gamma_1 I(patients_seen=51–100) + gamma_2 I(patients_seen=>100), k=1,2,3. References: Placebo, no prior history, 1–50 patients. No additional primary covariates are required.
6. Requested interaction OR is exp(beta_BH): the BCG-versus-placebo higher-severity OR among history-positive people divided by that among history-negative people, at fixed frequency. OR>1 means the BCG association shifts toward higher severity in those with history; it is not the joint BCG/history OR or the BCG effect within either stratum. Report a 95% CI, final sample size and severity counts, convergence/Hessian diagnostics, sparse-cell tables, and proportional-odds adequacy after approval.

CONSEQUENTIAL CHOICES FOR REVIEW
The data do not settle actual versus assigned vaccination, broad baseline history versus chronic disease, inclusion of asymptomatic/test-positive events, or AESEV versus an undocumented COVID-specific scale. AESEV exists for non-COVID events too: COVID severity must be defined by filtering events, not by analyzing AESEV globally. Including noncases at zero would instead combine infection risk and severity and is not proposed. Conditioning on COVID can induce selection bias; results should be described as adjusted association, not a causal interaction. Please approve the primary definitions above or specify changes before model fitting.
````

**Stage**

````text
plan
````

**Evidence**

````text
Executed inspection/inspect_inputs.py (inspection only), with detailed output in inspection/report.txt. Equality check MH CSV versus workbook returned True for the full DataFrame and every column. ID sets were equal across all three tables and treatment mismatches were zero. Additional direct pandas inspections established MH response-detail concordance, 31 history-uncertain subjects, four partially missing COVID-severity subjects, and seven negative-onset COVID records. No ordinal model or interaction estimate has been executed.
````

**Assumptions**

````text
[
  "TRTGRP represents the study BCG exposure comparison, not lifetime vaccination history.",
  "MHORRES=2 means yes and 1 means no in the medical-history subsection, inferred from record details.",
  "Higher AESEV codes represent greater severity; clinical labels are unavailable.",
  "Nonnegative AESTDTC identifies baseline-or-later events, subject to undocumented date origin."
]
````

**Uncertainties**

````text
[
  "Broad baseline medical history includes acute conditions and allergy; a chronic-only definition would change exposure coding.",
  "Worst observed severity may underestimate severity when additional COVID events lack scores.",
  "COVID-specific selection and treatment-group interpretation constrain causal conclusions.",
  "No supplied codebook confirms AESEV labels, date origin, or frequency measurement period."
]
````

### Event 15 — Simulator

**Message**

````text
Approved: execute the proposed person-level proportional-odds analysis with BCG, broad baseline medical history, their interaction, and categorical patients_seen adjustment. The proposed coding is defensible from the reported inspection, but retain the explicit caveats that treatment is assigned group, MH response meanings and severity ordering are inferred, and the date origin is undocumented. Use the specified complete-case history rule and worst recorded COVID-specific AESEV; do not treat noncases as severity zero or multiply rows through joins. The nonnegative-onset restriction is an analytical assumption, not a confirmed protocol rule; verify the reported finding that it does not change the severity-observed sample. Execute the proposed sensitivity excluding patients with both scored and unscored COVID records. Report the interaction coefficient, exp(coefficient), 95% CI and p-value, with its ratio-of-odds-ratios interpretation for higher severity. Include final inclusion counts, BCG-by-history severity cell counts, convergence and Hessian diagnostics, and a proportionate assessment of proportional-odds adequacy, acknowledging sparse upper categories. Retain an executable analysis script or notebook. Return a concise answer alongside diagnostics and the final submission fields: stage='final', answer, payload.executed_analysis=true only after execution, and artifacts.analysis pointing to the executed script or notebook. Describe the result as a conditional adjusted association rather than a causal effect.
````

**Interaction**

````text
next_task
````

**Phase**

````text
approach_review
````

**Action**

````text
continue
````

**Approve Approach**

````text
true
````

**Evidence**

````text
Inspection reports coherent subject-level joins, explicit treatment labels, ordered frequency categories, internally supported history coding, and 153 subjects with observed COVID-specific severity before history exclusions. The proposed model includes every requested predictor and adjustment and correctly defines the interaction OR. Remaining coding uncertainties are disclosed rather than presented as confirmed source intent; no model has yet been fitted.
````

**Objectives Open**

````text
[
  "Execute the agreed ordinal regression and estimate the BCG-by-history interaction odds ratio.",
  "Inspect sample construction, model diagnostics, and the targeted missing-severity sensitivity.",
  "Provide the concise final answer and executed-analysis artifact in the submission contract."
]
````

### Event 20 — Actor

**Answer**

````text
The adjusted BCG × prior-medical-history interaction odds ratio was **0.57** (95% CI **0.14–2.36**, p=**0.440**; interaction coefficient −0.5582), from a person-level proportional-odds model controlling for categorical patients_seen (n=147). This is the BCG-versus-placebo odds ratio for higher recorded COVID severity among history-positive patients divided by the corresponding odds ratio among history-negative patients. The estimate is imprecise and does not provide clear evidence of interaction. It is a conditional adjusted association among documented COVID cases, not a causal effect.
````

**Stage**

````text
result
````

**Evidence**

````text
Execution: python analysis.py completed successfully (exit code 0), retaining the nonempty executable script and machine-readable results.

Inclusion: 1,000 DM subjects; broad baseline history classification was 567 positive, 402 explicitly negative, 31 unknown. The four COVID-specific preferred terms yielded 224 records in 197 people. Restricting to nonnegative onset left 217 records in 190 people; 37 lacked any recorded severity, leaving 153. The script explicitly asserted that the severity-observed subject series and severity values were identical with and without the onset restriction. Six of the 153 had unknown history, leaving 147 complete cases; treatment and frequency were complete. No noncases were assigned zero severity, and history/outcomes were aggregated before one-person joins. The primary model used worst recorded severity and included three people with partially missing COVID severity; the fourth such person had already been excluded for unknown history.

BCG-by-history severity counts (columns severity 1,2,3,4):
BCG / no history: 5, 11, 1, 0 (n=17)
BCG / history: 21, 23, 7, 5 (n=56)
Placebo / no history: 11, 12, 0, 0 (n=23)
Placebo / history: 15, 31, 3, 2 (n=51)
Totals: 52, 77, 11, 7 (n=147).

Model: cumulative higher-severity log odds with BCG, history, BCG×history, and indicator adjustment for patients_seen=51–100 and >100. References were Placebo, no history, and 1–50 patients. Primary model converged with BFGS, warning flag 0, maximum absolute score 6.31e-7. Negative Hessian/information was positive definite, eigenvalue range 0.974–145.315, condition number 149.17. Thus local numerical diagnostics were satisfactory despite sparse upper outcome categories.

Sensitivity removing partially missing event histories: n=144, coefficient −0.6953, OR 0.4989, 95% CI 0.1181–2.1087, p=0.3444. It also converged with warning flag 0, maximum absolute score 4.89e-7, information eigenvalues 0.945–141.180, condition number 149.43. The substantive conclusion remained unchanged.

Proportional-odds assessment: upper categories are sparse. Placebo/no-history has no severity >2; neither no-history treatment group has severity >3. An attempted unconstrained threshold-specific logistic assessment failed with a singular Hessian, consistent with quasi-separation. The final script records cumulative cell diagnostics instead of presenting an unreliable formal slope-equality p-value. Proportional-odds adequacy remains uncertain; convergence of the primary constrained model does not validate the assumption.
````

**Assumptions**

````text
[
  "TRTGRP is assigned BCG versus placebo group, not verified administration or lifetime vaccination history.",
  "Within baseline MEDICAL HISTORY, MHORRES=2 is positive and 1 negative, inferred from detail-field concordance.",
  "Severity ordering 1<2<3<4 is inferred; no clinical category labels were supplied.",
  "AESTDTC>=0 was an approved analytical assumption; date origin was not documented. It did not change the severity-observed sample.",
  "History includes all affirmative baseline condition records, including allergies and acute conditions; any positive overrides unanswered conditions, but no observed positive plus an unanswered condition is unknown.",
  "Worst recorded COVID-specific AESEV is the outcome, not worst severity of any adverse event."
]
````

**Uncertainties**

````text
[
  "Wide confidence intervals permit substantial interaction in either direction.",
  "Conditioning on documented COVID and observed severity can induce selection bias; inference is not causal.",
  "Sparse upper severity categories prevent a reliable ordinary unconstrained proportional-odds diagnostic.",
  "Missing unscored event severities may underestimate a person's true maximum; the approved exclusion sensitivity was consistent with the primary result.",
  "The broad history definition and inferred coding are defensible but not confirmed by a supplied protocol or codebook."
]
````

### Event 21 — Simulator

**Message**

````text
The reported analysis addresses the question and agreed definitions adequately. Use the supplied final submission: interaction OR 0.57 (95% CI 0.14–2.36; p=0.440), adjusted for categorical patients_seen, n=147, interpreted as the ratio of BCG-versus-placebo higher-severity odds ratios in those with versus without prior history. Retain the conditional-association interpretation and note that sparse upper categories leave proportional-odds adequacy uncertain. Preserve stage='final', payload.executed_analysis=true, and artifacts.analysis='analysis.py'. No further analysis is requested.
````

**Interaction**

````text
conclude
````

**Phase**

````text
result_review
````

**Action**

````text
stop
````

**Approve Approach**

````text
false
````

**Evidence**

````text
The agent reports successful script execution, person-level aggregation, complete-case inclusion counts, the specified interaction and frequency adjustment, satisfactory convergence and positive-definite information, and a consistent missing-severity sensitivity. The onset restriction reportedly left observed outcomes unchanged. The failed unconstrained diagnostic is transparently attributed to sparse cells rather than represented as assumption validation. The final candidate includes the requested answer and execution-artifact fields.
````

**Objectives Open**

````text
[]
````

## Provenance

````text
{
  "source_run": "runs/openai-astra-top2-first-pass",
  "repair_run": "runs/repair-1-openai-astra-top2-first-pass",
  "event_log": "runs/openai-astra-top2-first-pass/episodes/bixbench_bix-29-q3-234cb2c5acad/persona_off/attempt-1/output/bixbench_bix-29-q3-234cb2c5acad/controller/events.jsonl",
  "event_log_sha256": "28ccd41341cdccb6bf5c0315ce45a27cff48c175a5c7fb18561990e2b9b834b0",
  "models": {
    "actor": {
      "model": "gpt-6-astra",
      "provider": "openai",
      "reasoning_effort": "low"
    },
    "researcher": {
      "model": "gpt-6-astra",
      "provider": "openai",
      "reasoning_effort": "low"
    },
    "judge": {
      "model": "gpt-6-astra",
      "provider": "openai",
      "reasoning_effort": "low"
    }
  }
}
````
